Trial design: 2,339 participants Adults with obesity or overweight + at least one weight-related complication Participants did NOT have diabetes Randomized to placebo or retatrutide 4 mg, 9 mg or 12 mg 80-week double-blind trial Pre-specified extension to 104 weeks in participants with BMI 35 Weight loss results at 80 weeks: 4 mg: -19.0% (~47 lbs / 21.4 kg) 9 mg: -25.9% (~64 lbs / 29.2 kg) 12 mg: -28.3% (~70 lbs / 31.9 kg) That degree of weight loss approaches levels traditionally associated with bariatric surgery
It is a powerful antioxidant that fights sun damage, treats hyperpigmentation, fights signs of aging, makes your skin plumpy, stimulates collagen production, giving you a glowing complexion while firming the skin
Pediatr Res 1969;3(5):448458
These findings suggest an overall improvement in the lipoprotein profile associated with atherogenic risk
Reduces Appetite The drug acts on areas of the brain that control hunger
What can a vitamin IV drip be used for